US Medical Innovations Raises $10.2 M in Private Placement by Admin-USMI | Sep 21, 2022 | News Release, News Release 2022Takoma Park, MDRead Press...
JCRI – ABTS and USMI to Present a Two-year Follow-up of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at Israeli Society of Surgical Oncology by Admin-USMI | May 12, 2022 | News Release, News Release 2022Takoma Park, MDRead Press...
JCRI DISCOVERS REGULATORY GENE BCL2A1 FOR TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER by Admin-USMI | Mar 15, 2022 | News Release, News Release 2022Takoma Park, MDRead Press...
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases by Admin-USMI | Oct 6, 2021 | News Release, News Release 2021Takoma Park, MDRead Press...
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference by Admin-USMI | Sep 9, 2021 | News Release, News Release 2021Takoma Park, MDRead Press...
JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer by Admin-USMI | Sep 2, 2021 | News Release, News Release 2021Takoma Park, MDRead Press...
